- Home
- RVSN vs NLSP Comparison
RVSN vs NLSP Comparison
Compare RVSN & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- NLSP
- Stock Information
- Founded
- RVSN 2016
- NLSP 2015
- Country
- RVSN Israel
- NLSP Switzerland
- Employees
- RVSN N/A
- NLSP N/A
- Industry
- RVSN
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- RVSN
- NLSP Health Care
- Exchange
- RVSN Nasdaq
- NLSP Nasdaq
- Market Cap
- RVSN 6.6M
- NLSP 5.9M
- IPO Year
- RVSN 2022
- NLSP 2021
- Fundamental
- Price
- RVSN $0.44
- NLSP $1.50
- Analyst Decision
- RVSN
- NLSP
- Analyst Count
- RVSN 0
- NLSP 0
- Target Price
- RVSN N/A
- NLSP N/A
- AVG Volume (30 Days)
- RVSN 1.1M
- NLSP 102.5K
- Earning Date
- RVSN 05-06-2025
- NLSP 05-14-2025
- Dividend Yield
- RVSN N/A
- NLSP N/A
- EPS Growth
- RVSN N/A
- NLSP N/A
- EPS
- RVSN N/A
- NLSP N/A
- Revenue
- RVSN $1,300,000.00
- NLSP N/A
- Revenue This Year
- RVSN $1,861.54
- NLSP N/A
- Revenue Next Year
- RVSN N/A
- NLSP N/A
- P/E Ratio
- RVSN N/A
- NLSP N/A
- Revenue Growth
- RVSN 815.49
- NLSP N/A
- 52 Week Low
- RVSN $0.27
- NLSP $1.30
- 52 Week High
- RVSN $2.72
- NLSP $18.40
- Technical
- Relative Strength Index (RSI)
- RVSN 53.37
- NLSP 49.86
- Support Level
- RVSN $0.36
- NLSP $1.38
- Resistance Level
- RVSN $0.43
- NLSP $1.53
- Average True Range (ATR)
- RVSN 0.05
- NLSP 0.09
- MACD
- RVSN 0.02
- NLSP 0.02
- Stochastic Oscillator
- RVSN 82.69
- NLSP 64.91
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.